Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of COVID-19 on Unplanned Admissions for Acute Cardiovascular and Neurovascular Conditions in France

NCT04542083 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04542083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04542083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of COVID-19 on Unplanned Admissions for Acute Cardiovascular and Neurovascular Conditions in France
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Terminated
Start date
September 20, 2021
Completion date
July 25, 2023
Enrollment
911 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute cardiovascular condition, acute myocardial infarction, acute neurovascular condition, covid-19, stroke